DNA Methylation

DNA Methylation

Introduction

Dna Methylation is an important component in the neurobiology of neurodegenerative [diseases](/diseases). This page provides detailed information about its structure, function, and role in disease processes.

Overview

DNA methylation is an epigenetic modification involving the addition of a methyl group to the 5-position of cytosine residues in DNA (forming 5-methylcytosine, 5mC). This reversible, heritable modification regulates gene expression without altering the underlying DNA sequence and plays crucial roles in brain development, neuronal identity, [synaptic plasticity](/mechanisms/synaptic-plasticity), and [aging](/diagnostics/neuroimaging). Aberrant DNA methylation patterns are increasingly recognized as a core feature of [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative disorders, linking environmental exposures and aging to altered gene expression and neuronal vulnerability ([Coppieters et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25245166/); [Day & Bhatt, 2024](https://pmc.ncbi.nlm.nih.gov/articles/PMC11045197/)). [@portela2010]

DNA methylation is part of a broader epigenetic landscape that includes [histone modifications](/entities/histone-modifications), non-coding RNA regulation, and chromatin remodeling, all of which interact to determine gene expression states in the aging and diseased brain. [@globisch2010]

Molecular Mechanisms

DNA Methyltransferases (DNMTs)

DNA Methylation

Introduction

Dna Methylation is an important component in the neurobiology of neurodegenerative [diseases](/diseases). This page provides detailed information about its structure, function, and role in disease processes.

Overview

DNA methylation is an epigenetic modification involving the addition of a methyl group to the 5-position of cytosine residues in DNA (forming 5-methylcytosine, 5mC). This reversible, heritable modification regulates gene expression without altering the underlying DNA sequence and plays crucial roles in brain development, neuronal identity, [synaptic plasticity](/mechanisms/synaptic-plasticity), and [aging](/diagnostics/neuroimaging). Aberrant DNA methylation patterns are increasingly recognized as a core feature of [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative disorders, linking environmental exposures and aging to altered gene expression and neuronal vulnerability ([Coppieters et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25245166/); [Day & Bhatt, 2024](https://pmc.ncbi.nlm.nih.gov/articles/PMC11045197/)). [@portela2010]

DNA methylation is part of a broader epigenetic landscape that includes [histone modifications](/entities/histone-modifications), non-coding RNA regulation, and chromatin remodeling, all of which interact to determine gene expression states in the aging and diseased brain. [@globisch2010]

Molecular Mechanisms

DNA Methyltransferases (DNMTs)

Three major DNMT enzymes catalyze methylation reactions ([Portela & Esteller, 2010](https://pubmed.ncbi.nlm.nih.gov/22293439/)): [@day2015]

| Enzyme | Type | Key Function | Brain Expression | [@day2024]
|--------|------|-------------|-----------------| [@ref]
| DNMT1 | Maintenance | Copies methylation patterns to daughter strands during DNA replication | High in post-mitotic [Neurons](/cell-types/neurons); maintains neuronal identity | [@horvath2013]
| DNMT3A | De novo | Establishes new methylation marks | Active in adult [neurogenesis](/entities/neurogenesis) and synaptic plasticity | [@smart2018]
| DNMT3B | De novo | Establishes methylation during embryonic development | Lower postnatal expression; variants linked to ICF syndrome | [@refa]
| DNMT3L | Regulatory | Stimulates DNMT3A/B activity; lacks catalytic domain | Important in genomic imprinting | [@levine2018]

Methylation and Demethylation Cycle

DNA methylation is a dynamic, reversible process: [@npj2025]

5-hydroxymethylcytosine (5hmC) is particularly abundant in the brain — approximately 10-fold higher than other tissues — and is enriched at active gene bodies and enhancers, where it serves as a stable epigenetic mark rather than merely a transient intermediate ([Globisch et al., 2010](https://pubmed.ncbi.nlm.nih.gov/22353756/)). [@lord2014]

CpG Context and Gene Regulation

| Methylation Context | Effect on Expression | Brain Relevance |
|-------------------|---------------------|-----------------|
| CpG island promoters | Methylation → silencing | Controls expression of synaptic and neuronal identity [genes](/genes) |
| Gene bodies | Methylation → active transcription | Regulates alternative splicing; enriched for 5hmC in [Neurons](/cell-types/neurons) |
| Enhancers | Cell-type-specific methylation patterns | Determines [neurons](/entities/neurons) vs. glia] gene expression programs |
| Non-CpG (CpH) methylation | Unique to [Neurons](/cell-types/neurons); brain-specific | Accumulates during postnatal brain maturation; may regulate neuronal gene expression |
| Repetitive elements | Methylation maintains silencing | Loss of methylation at LINE-1 elements linked to [aging and neurodegeneration](/mechanisms/aging-neurodegeneration) |

DNA Methylation in the Brain

[Neurons](/cell-types/neurons)-Specific Epigenetic Landscape

The brain exhibits unique methylation characteristics not seen in other tissues:

• High 5hmC levels: Brain has the highest 5hmC content of any organ, particularly in [Neurons](/cell-types/neurons) of the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and [cerebellum](/brain-regions/cerebellum)
• Non-CpG methylation: [Neurons](/cell-types/neurons) accumulate substantial CpH methylation (CpA, CpT, CpC) during postnatal development — a feature unique to brain cells
• Cell-type specificity: Dramatic differences in methylation patterns between [Neurons](/cell-types/neurons), [Astrocytes](/cell-types/astrocytes), [microglia:
• Global DNA hypomethylation in vulnerable regions ([hippocampus](/brain-regions/hippocampus), [entorhinal cortex](/brain-regions/entorhinal-cortex), [prefrontal [cortex)
• Reduced 5hmC levels, particularly in hippocampal [Neurons](/cell-types/neurons)
• Epigenome-wide association studies (EWAS) have identified hundreds of differentially methylated positions (DMPs) associated with AD neuropathology
• Cell-type deconvolution reveals that many DMPs in bulk [cortex](/brain-regions/cortex) tissue reflect methylation changes in non-neuronal cells ([microglia](/cell-types/microglia)/cell-types/microglia:**
• [BDNF](/proteins/bdnf): Reduced trophic support for hippocampal and cortical [Neurons](/cell-types/neurons)
• ANK1: Consistently identified as hypermethylated in the [entorhinal cortex](/brain-regions/entorhinal-cortex); one of the most robust EWAS findings in AD
• HOXA3, BIN1, RHBDF2: Genome-wide significant DMPs replicated across multiple cohorts
• SYP, CREB: Synaptic plasticity genes with reduced expression

• **[BACE1](/entities/bace1) can slow epigenetic aging

DNA Methylation in Other Neurodegenerative Diseases

Parkinson's Disease

• Altered methylation at the [SNCA](/genes/snca) locus: hypomethylation of SNCA intron 1 increases [alpha-synuclein](/proteins/alpha-synuclein) expression
• [LRRK2](/genes/lrrk2) and [GBA](/genes/gba) methylation changes in PD blood and brain
• Accelerated epigenetic aging in [substantia nigra](/brain-regions/substantia-nigra) dopaminergic [neurons](/entities/neurons)

ALS

• [C9orf72](/genes/c9orf72) repeat expansion carriers show hypermethylation of the [C9orf72](/genes/c9orf72) promoter
• Aberrant methylation of [SOD1](/proteins/sod1-protein) and [TARDBP](/genes/tardbp) loci
• Epigenetic aging of motor [Neurons](/cell-types/neurons) in [ALS](/diseases/amyotrophic-lateral-sclerosis)

Huntington's Disease

• Altered methylation patterns near the [HTT](/genes/htt) locus in [Huntington's disease](/diseases/huntingtons)
• Accelerated epigenetic aging in striatal tissue correlates with CAG repeat length

Therapeutic Implications

Pharmacological Approaches

DNMT inhibitors:

• 5-azacytidine (Vidaza) and decitabine: FDA-approved for hematological malignancies; preclinical AD studies show mixed results
• RG108: Non-nucleoside DNMT inhibitor with improved safety profile
• Challenges: Lack of gene specificity; global demethylation may activate deleterious genes

• Vitamin C enhances TET enzyme activity and promotes 5hmC formation
• Restoring 5hmC levels may be therapeutically beneficial in AD

• Interact with DNA methylation pathways; combined epigenetic therapy approaches under investigation

Precision Epigenetic Editing

• CRISPR-dCas9-DNMT3A: Targeted methylation of specific genomic loci without altering DNA sequence
• CRISPR-dCas9-TET1: Targeted demethylation for reactivating silenced genes
• Proof-of-concept in neuronal cultures; delivery challenges for CNS applications

Lifestyle and Dietary Interventions

Modifiable factors that influence brain DNA methylation:

• Methyl donors: Folate, vitamin B12, B6, choline, betaine — support SAM synthesis for methylation reactions
• Exercise: Aerobic exercise modulates DNA methylation at [BDNF](/proteins/bdnf) and inflammatory gene loci
• Mediterranean diet: Associated with slower epigenetic aging
• Cognitive engagement: Learning and enrichment drive activity-dependent methylation changes
• Sleep: Sleep disruption alters circadian methylation patterns

External Links

• [NIH Roadmap Epigenomics](https://www.roadmapepigenomics.org/)

Background

The study of Dna Methylation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying [mechanisms of neurodegeneration/mechanisms) and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas: [DNA Methylation expression search](https://human.brain-map.org/microarray/search/show?search_term=DNA+Methylation)
• Allen Mouse Brain Atlas: [DNA Methylation search](https://mouse.brain-map.org/search/index.html?query=DNA+Methylation)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Developmental Transcriptome: [DNA Methylation developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=DNA+Methylation)

See Also

• [Neurons](/cell-types/neurons)
• [Astrocytes](/cell-types/astrocytes)
• [BDNF](/proteins/bdnf)
• [alpha-synuclein](/proteins/alpha-synuclein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Huntington's Disease](/diseases/huntingtons)
• [Microglia](/entities/microglia)
• [neuroinflammation](/mechanisms/neuroinflammation)

References

Pathway Diagram

Pathway Diagram

The following diagram shows the key molecular relationships involving DNA Methylation discovered through SciDEX knowledge graph analysis: